Monthly Archives: February 2017

28 February 2017

Sphere Medical – Results for the year ended 31 December 2016

By |February 28th, 2017|

Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, announces its results for the year ended 31 December 2016.
 
Business highlights for 2016 and post year-end
 
·        Successful commercial launch of Proxima 4 in mid-December 2016 in Europe with encouraging early market reaction
·        First sales of Proxima 4 achieved
·        Over 20 […]

Parkwalk closes PhoreMost follow-on investment

By |February 28th, 2017|

We are pleased to announce that Parkwalk has made an investment in Phoremost, a Cambridge University spinout, as part of a Series ‘B’ round of equity funding, alongside Amadeus Capital Partners and the University. Phoremost’s mission is to accelerate, diversify and rationalise drug discovery.

PhoreMost has developed a next-generation phenotypic screening platform called ‘SiteSeeker’ to identify […]

Arkivum and UKCloud announce partnership for public sector archiving

By |February 28th, 2017|

28 Feb 2017

Arkivum, a provider of long term digital safeguarding and preservation solutions and UKCloud, a Cloud Service Provider focused exclusively on the UK Public Sector, today announced a partnership to leverage the growing requirements for long term data management strategies within the UK public sector. Arkivum has been appointed as a Preferred Partner […]

8power – Joins the LoRa Alliance™

By |February 17th, 2017|

8power is pleased to announce membership of the LoRa Alliance™, a global industry group to promote the development and deployment of the LoRaWAN™ Low Power Wide Area Network (LPWAN) open standard. The Alliance represents many of the leading players in the wireless Internet of Things community, including global enterprises, major network operators, service providers, […]

Congenica – Parkwalk closes investment

By |February 15th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund and the Parkwalk Technology Fund VII have invested in a $10m Series ‘B’ financing round for Congenica Limited, which spun out of the Wellcome Trust Sanger Institute and Department of Health. Congenica has developed software that enables the accurate, rapid and scalable clinical interpretation of […]

Sphere Fluidics – Parkwalk closes further funding round

By |February 15th, 2017|

We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously.

Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area.

The company was founded on IP generated by the University of Cambridge and has […]

Covatic – University of Oxford Innovation Fund III investment

By |February 15th, 2017|

Covatic is building the world’s first broadcast personalisation engine, based on world-leading IP from the University of Oxford in the field of semantic linked-data technology.  It will enable broadcasters to deliver context aware, dynamic programming tailored to the unique requirements of each audience member.

The company was founded in early 2017 by a combination of […]

Focal Point Positioning – University of Cambridge Enterprise Fund IV investment

By |February 15th, 2017|

Focal Point was founded in June 2015 with Dr Ramsey Faragher as CEO and CTO. The team had originally worked on a range of platforms seeking to improve the navigational and positioning systems on vehicles as diverse as submarines and Martian rovers. They then decided to bring that 30 years of combined knowledge to bear […]

Parkwalk wins at EISA Awards

By |February 2nd, 2017|

Parkwalk are delighted to have won both the ‘Best Investment Exit’ and ‘Best EIS Fund Manager’ categories at the EISA awards on the 1st February 2017. The awards recognised an extremely strong 2016 for Parkwalk. They were presented at the House of Lords to firms, advisers, companies and individuals that achieved outstanding performance in the context […]